Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





iPS stem cells repair damaged mouse hearts

20 July 2009

By Dr Will Fletcher

Appeared in BioNews 518

Induced pluripotent stem cells (iPS cells)  have been used to repair damaged heart tissue in mice by a team from the Mayo Clinic in Rochester, Minnesota, US. iPS cells are adult cells that are reprogrammed to act like embryonic stem cells - in this case the iPS cells were derived from ordinary fibroblasts (cells that contribute to scars such as those resulting from a heart attack). When the cells were injected into mice whose hearts had been damaged by a heart attack they improved both the structure and function of the heart. This proof-of-concept study, published in the online issue of the journal Circulation, is the first attempt to use iPS cells to treat heart disease and shows a potential practical use for these experimental cells.

Stem cells offer a vast range of possibilities for regenerative medicine because they can be coaxed into forming 'lab-dish' replacements for cells from the heart, liver, skin, eye, nerve or brain. Since iPS stem cells come from adult tissue their use is considered less controversial than embryonic stem cells that come from embryos only a few days old. Another advantage is that iPS cells are derived from a patient's own cells, so their use effectively eliminates the risk of organ rejection and the dangers associated with anti-rejection drugs. The eventual goal is to one day be able to use a patient's own cells to repair their heart instead of replacing it with a donated heart which are in short supply.

'This study establishes the real potential for using iPS cells in cardiac treatment,' says Dr Timothy Nelson, the study's principal author, adding: 'Bioengineered fibroblasts acquired the capacity to repair and regenerate infarcted hearts (hearts with an area of tissue death due to a local lack of oxygen).'

There are several ways to make iPS cells but in this study Nelson and his team used a virus to transplant genes that 'turned back the clock' on the fibroblast cells. Then, instead of coaxing the iPS cells into a specific type of heart tissue, they transplanted the iPS cells in their most embryonic state. It was found that only two weeks after transplantation the iPS cells had begun making different types of tissue such as heart muscle and blood vessels. Within four weeks the team discovered the cells had actually managed to stop progression of structural damage, restore heart muscle performance lost after the heart attack, and regenerate tissue at the site of the damage.

'We're taking advantage of a diseased tissue environment that is sending out a distress signal that is asking the tissue to repair itself... when we put these iPS cells in, they are able to respond,' Nelson said. ‘They were able to respond to this damaged environment and spontaneously give rise to the appropriate tissues and create new tissues within that diseased heart,' he continued, adding 'that is a key wow factor of this paper.'

 

SOURCES & REFERENCES

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

13 June 2011 - by Dr Sophie Pryor 
A naturally occurring protein can activate stem cells in mouse hearts, producing new muscle cells to replace the tissue damaged by a heart attack, UK scientists have found... [Read More]
12 April 2010 - by Dr Rachael Panizzo 
Researchers at the Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine have pinpointed key genetic differences between mouse embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells).... [Read More]
07 September 2009 - by Dr Will Fletcher 
Light-sensing retinal eye cells have been grown from human skin cells for the first time. This raises the future possibility of restoring vision to patients with retinas damaged by certain degenerative diseases, by growing rescue or repair cells from the patient's skin... [Read More]

02 March 2009 - by Antony Blackburn-Starza 
Researchers in the UK and Canada have successfully created induced pluripotent stem (iPS) cells suitable for potential future use in humans. iPS cells are adult cells (in this case skin cells) that have been reprogrammed into a pluripotent embryonic-like state, able to divide into any cell in... [Read More]
02 February 2009 - by Dr Will Fletcher 
A special class of adult stem cells, known as human induced pluripotent stem (iPS) cells, has for the first time been reprogrammed into cells that develop into human eggs and sperm. The research, carried out by members of the University of California, Los Angeles (UCLA)'s Broad... [Read More]
14 April 2008 - by Evelyn Harvey 
Nerve tissue derived from stem cells made from reprogrammed skin developed into normal brain tissue and relieved symptoms of Parkinson's disease in rats, in a study published in the journal Proceedings of the National Academy of Sciences of the USA (PNAS) last week. Scientists at the Whitehead... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation